About US
Contact us
-
China may not produce for Big Pharma long-termChina, already the third-largest drug market in the world,yesterday was again placed among the 16 "pharmerging" identified by IMS Health's Institute for Healthcare Informatics. The health information2012/7/16
-
Foreign demand saves Ipsen's primary-care plantIpsen's news isn't all bad these days. After its big plans for a new hemophilia drug hit a big snag earlier this week, the drugmaker is announcing plans to keep a French plant it had slated for sale.2012/7/13
-
Emerging markets to dominate as drug sales hit $1.2TIt's no wonder that Big Pharma is looking to emerging markets to lift sales. These fast-growing countries are about the only areas where drug spending will increase significantly. The global drug mark2012/7/13
-
J&J to tighten up on oversight in wake of recalls, lawsuitsJohnson & Johnson ($JNJ) is pledging to keep a sharper eye on drug manufacturing and marketing. Specifically, its board promises to get involved in oversight, to prevent the sort of misbehavior th2012/7/12
-
Lilly aims to harmonize its social-media voicesEli Lilly ($LLY) wants to speak with one voice online. But interest in social media is growing throughout the company. So, Lilly communications specialists are working on a unified social media strate2012/7/12
-
Novartis plant snafu sends desperate Excedrin users to eBayJohnson & Johnson ($JNJ) isn't the only drugmaker struggling to get recalled over-the-counter products back on store shelves. Novartis ($NVS) hasn't yet restocked brands pulled back in January, an2012/7/11
-
FDA plan requires opioid makers to fund anti-abuse CMEMaking strong painkillers now comes with extra responsibility. The FDA has unveiled new measures aimed at nipping opioid abuse in the bud. They require drugmakers to fund educational courses for doc2012/7/11
-
BMS, Lilly's targeted drug Erbitux gets new FDA nodErbitux from Bristol-Myers Squibb ($BMY) and Eli Lilly ($LLY) has received a new first-line approval for targeted use against colorectal cancer. The agency OK comes along with approval for a companion2012/7/10
-
Natco's generic of Bayer's Nexavar hits India marketNatco Pharma's generic version of Bayer'sNexavar has hit the market in India, a gift to poor Indians from the government patent office in a move threatening international repercussions. A Natco execu2012/7/10
-
Pfizer trimming health claims on CentrumWhether Pfizer ($PFE) is bowing to pressure from a public interest group or ducking for cover for questionable advertising, it says it has decided within the next month to remove some health claims fr2012/7/9